Lee Y-S. Mesenchymal stem cell-conditioned media recovers lung fibroblasts from cigarette smoke-induced damage. Am J Physiol Lung Cell Mol Physiol 302: L891-L908, 2012. First published February 3, 2012 doi:10.1152/ajplung.00288.2011.-Cigarette smoking causes apoptotic death, senescence, and impairment of repair functions in lung fibroblasts, which maintain the integrity of alveolar structure by producing extracellular matrix (ECM) proteins. Therefore, recovery of lung fibroblasts from cigarette smoke-induced damage may be crucial in regeneration of emphysematous lung resulting from degradation of ECM proteins and subsequent loss of alveolar cells. Recently, we reported that bone marrow-derived mesenchymal stem cell-conditioned media (MSC-CM) led to angiogenesis and regeneration of lung damaged by cigarette smoke. In this study, to further investigate reparative mechanisms for MSC-CM-mediated lung repair, we attempted to determine whether MSC-CM can recover lung fibroblasts from cigarette smoke-induced damage. In lung fibroblasts exposed to cigarette smoke extract (CSE), MSC-CM, not only inhibited apoptotic death, but also induced cell proliferation and reversed CSE-induced changes in the levels of caspase-3, p53, p21, p27, Akt, and p-Akt. MSC-CM also restored expression of ECM proteins and collagen gel contraction while suppressing CSE-induced expression of cyclooxygenase-2 and microsomal PGE 2 synthase-2. The CSE-opposing effects of MSC-CM on cell fate, expression of ECM proteins, and collagen gel contraction were partially inhibited by LY294002, a phosphatidylinositol 3-kinase (PI3K) inhibitor. In rats, MSC-CM administration also resulted in elevation of p-Akt and restored proliferation of lung fibroblasts, which was suppressed by exposure to cigarette smoke. Taken together, these data suggest that MSC-CM may recover lung fibroblasts from cigarette smoke-induced damage, possibly through inhibition of apoptosis, induction of proliferation, and restoration of lung fibroblast repair function, which are mediated in part by the PI3K/Akt pathway. cigarette smoking; chronic obstructive pulmonary disease; emphysema CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), a leading cause of death worldwide, is most often caused by cigarette smoking. COPD is characterized by expiratory airflow limitation that is not fully reversible, accompanying inflammation, and emphysematous destruction of the lung (39). Irrespective of the high incidence and mortality rates for COPD, most current therapies for this disease are supportive, and regenerative therapies to cure emphysema are not available.
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As a pathophysiological mechanism, proteolytic degradation of extracellular matrix (ECM) by protease activities overwhelming antiprotease activities has long been suspected to be responsible for the emphysematous change seen in patients with COPD (45) . Lung fibroblasts are considered crucial for maintenance of the integrity of alveolar structure by producing ECM proteins, including collagen, elastin, and fibronectin, which are required for attachment, structure, and function of alveolar epithelial cells (13) . Cigarette smoke extract (CSE) causes suppression of proliferation (36) , apoptotic death (10), senescence (38) , and inhibition of collagen gel contraction (9) in lung fibroblasts in vitro. Similarly, lung fibroblasts from patients with COPD show reductions in cell proliferation (17) , chemotaxis, and collagen gel contraction (48) , effects suggesting that cigarette smoke may interfere with reparative roles of lung fibroblasts.
Recently, attempts have been made by researchers to develop a therapeutic modality using stem cell therapy in treatment of lung diseases. In bleomycin-induced lung injury, human umbilical cord mesenchymal stem cells (MSCs) were found to attenuate inflammation and to reduce collagen deposition (34) . In addition, MSCs were found to ameliorate monocrotaline-induced pulmonary hypertension (5) and endotoxininduced acute lung injury (15) . Furthermore, Schweitzer et al. (43) demonstrated attenuation of inflammatory infiltration and emphysematous change by adipose stem cells with scare engraftment of donor cells in lungs of cigarette smoke-exposed mice and improvement of lung endothelial repair in vitro by cell-free stem cell-conditioned media, suggesting that the beneficial effects of stem cells may be mediated via a paracrine mechanism. Consistent with the idea of a paracrine action of stem cells, bone marrow stromal cell-conditioned media was found to cause alveolarization in a hyperoxia-induced bronchopulmonary dysplasia model (4) . Similarly, we recently reported that cell-free MSC-conditioned media (MSC-CM) is equipotent to MSCs in lung regeneration and increased formation of small pulmonary vessels, which is suggested as one of the reparative mechanisms in cigarette smoke-induced emphysema (18) . However, even though vascular protective and angiogenic effects of conditioned media of stem cells have been proposed as one of the mechanisms for lung repair in animal models of emphysema (18, 43) and bronchopulmonary dysplasia (4) , effects of stem cell-conditioned media on lung fibroblasts have been barely demonstrated in the context of repair of lung damaged by cigarette smoke.
As lung fibroblasts play an important role in maintenance of alveolar architecture and cigarette smoking is known to cause apoptotic death, senescence, or impairment of repair function in lung fibroblasts, recovery of lung fibroblasts is supposed to be beneficial in lung repair. Herein, we demonstrate that MSC-CM inhibited apoptotic death, induced cell proliferation, and restored expression of ECM proteins and collagen gel contraction in CSE-exposed lung fibroblasts while suppressing CSE-induced expression of cyclooxygenase (COX)-2 and microsomal PGE 2 synthase-2. In addition, we evaluated proliferation of lung fibroblasts in rats that were exposed to cigarette smoke and treated with MSC-CM.
MATERIALS AND METHODS
Reagents and antibodies. Chemicals were purchased from Sigma (St. Louis, MO) and Calbiochem (La Jolla, CA). Antibodies were obtained from the following sources: anti-cleaved caspase 3, anti-Akt, anti-p-Akt (S473), anti-vimentin, anti-proliferating cell nuclear antigen (PCNA), horseradish peroxidase (HRP)-conjugated anti-mouse IgG, and HRP-conjugated anti-rabbit IgG (Cell Signaling, Beverly, MA), FITC-conjugated anti-annexin V, anti-p53, anti-p21, anti-fibronectin, and nonimmune mouse and rabbit IgG (Santa Cruz Biotechnology, Santa Cruz, CA), anti-p27 (BD Biosciences, San Jose, CA), mouse anti-transforming growth factor-␤ 1 (TGF-␤1), rabbit anti-fibroblast growth factor 2 (FGF-2), rabbit anti-vascular endothelial growth factor (VEGF) (Abcam, Cambridge, MA), anti-collagen 1 (Rockland, Gilbertsville, PA), and FITC-conjugated anti-rabbit IgG and Alexa Fluor 647-conjugated anti-goat IgG, Alexa Fluor 488-conjugated anti-rabbit IgG, and Alexa Fluor 555-conjugated antimouse IgG (Invitrogen, Carlsbad, CA).
CSE preparation and treatment. CSE was prepared as previously described (18, 38) . Briefly, 40 ml of cigarette smoke (Eighty Eight Light, containing 8.5 mg tar and 0.9 mg nicotine/cigarette; KT & G, Daejun, Korea) drawn into a 50-ml plastic syringe through a threeway cock was mixed with 10 ml of DMEM (Invitrogen) by vigorous shaking. One cigarette was used per 10 ml CSE, and CSE was prepared no more than 30 min before use in experiments. CSE solution filtered through a 0.22-m filter was considered as 100%. Lung fibroblasts grown overnight in DMEM containing 10% FBS was washed with PBS and exposed to CSE in serum-free DMEM for 24 h. The next day, to assess MSC-CM effects, lung fibroblasts were washed with PBS and cultured in fresh serum-free DMEM or MSC-CM for an additional 24 h.
Preparation of bone marrow-derived MSC-CM. The animal experimental protocol was approved by the Institutional Animal Care and Use Committee of Asan Medical Center. MSC-CM was prepared from plastic-adherent rat MSCs, as in our previous report (18) . In brief, following collection of bone marrow cells from femurs and tibias of 5-7-wk-old male Lewis rats, mononuclear cells were isolated by Percoll (Amersham, Piscataway, NJ) density gradient centrifugation (d ϭ 1.084). Bone marrow mononuclear cells were cultured in plastic tissue culture dishes in DMEM supplemented with 10% FBS and penicillin-streptomycin. After 3 days, nonadherent cells were washed out, and culture media was changed once or twice per week. The multipotent differentiating capability and MSC surface markers were confirmed, as in our previous report (18) . Rat MSC-CM was prepared from third to fifth passage rat MSCs. At 90% confluence in 15-cm diameter culture dishes (about 1.8 ϫ 10 7 cells), MSCs were washed three times with PBS and cultured in 50 ml fresh serum-free DMEM. After 24 h, MSC-CM was collected and filtered through a 0.22-m filter. Filtered media were concentrated tenfold using a 3-kDa cutoff ultrafiltration membrane (YM-3; Amicon, Beverly, MA). MSC-CM and the pass-through fraction (PT) were frozen in liquid nitrogen and stored at Ϫ70°C until use. In some experiments, tenfold concentrated MSC-CM was diluted with fresh serum-free DMEM. Serum-free DMEM was used as a control medium because we observed in the previous study that conditioned media derived from lung fibroblasts and human pulmonary artery smooth muscle cells (HPASMCs), similar to serum-free DMEM, had no effect on survival of CSE-damaged lung fibroblasts and pulmonary artery endothelial cells, whereas MSC-CM protected the target cells (18) . To observe human MSC-CM effects on normal human lung fibroblasts (NHLFs; Lonza, Rockland, ME), human MSC-CM (hMSC-CM) was prepared from human bone marrow-derived MSCs (Lonza) of passage 7 grown in StemPro MSC serum-free medium (Invitrogen). At 90% confluence in 15-cm diameter culture dishes (around 1.8 ϫ 10 7 cells), human MSCs were washed three times with PBS and cultured in 30 ml fresh serum-free DMEM. After 24 h, hMSC-CM was collected and concentrated in the same manner as described above. In addition, to compare with MSC-CM, 10ϫ conditioned media were prepared from RFL-6 cells, HPASMCs (Lonza), and NHLFs in the same way as described above.
MTT and BrdU uptake assay. NHLFs or rat fetal lung fibroblasts (RFL-6, American Type Culture Collection, Manassas, VA) were cultured in DMEM with 10% FBS and penicillin-streptomycin. We seeded 5 ϫ 10 3 NHLFs of seventh to ninth passage, or an equivalent number of RFL-6 cells of third to eighth passage per well on a 96-well plate. A 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay (Roche, Indianapolis, IN) or a bromodeoxyuridine (BrdU) uptake assay (Calbiochem) was performed according to the manufacturer's instructions for determination of the number of live cells or proliferation, respectively.
FACS analysis. At 70% confluence, lung fibroblasts were washed with PBS, and exposed to CSE in the absence of serum for 24 h. After detachment with trypsin-EDTA (Invitrogen), lung fibroblasts were fixed overnight in 70% ethanol at Ϫ20°C, treated with 5 g/ml RNase (Roche), and stained with 0.1 mg/ml propidium iodide (Sigma). A fluorescence-activated cell sorting (FACS) Calibur flow cytometer and the CELL QUEST analysis program (BD Biosciences) were used in analysis of a total of 10,000 cells.
TUNEL assay and annexin V staining. Lung fibroblasts attached on glass cover slips (22 ϫ 22 mm; Corning, Lowell, MA) at 70% confluence were cultured overnight in a six-well plate with DMEM containing 10% FBS and penicillin-streptomycin. Lung fibroblasts were washed with PBS, exposed to CSE for 24 h, and cultured in fresh serum-free DMEM or MSC-CM for an additional 24 h in the absence of CSE. The cells were then fixed with 4% paraformaldehyde in PBS for 20 min, permeabilized with 0.1% Triton X-100 in PBS, incubated with 2% BSA in PBS for 1 h at room temperature, and incubated overnight with FITC-conjugated anti-annexin V antibody (1:500) at 4°C. After the cells were washed with PBS containing 0.1% Tween-20, a TUNEL assay (Roche) was performed according to the manufacturer's instructions.
Western blot analysis. Lung fibroblasts were lysed with lysis buffer (20 mM Tris·HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 0.1% SDS, 1% NP-40, 2.5 mM sodium pyrophosphate, 1 mM ␤-glycerophosphate, 1 mM Na3VO4, 2 mM P-nitrophenyl phosphate, and a protease inhibitor cocktail) on ice for 30 min. After centrifugation at 14,000 g for 20 min at 4°C, proteins in supernatants were separated in a 10 or 15% SDS-PAGE gel and transferred to a nitrocellulose membrane. Membranes were blocked with 5% skim milk for 1 h at room temperature, followed by incubation with primary antibodies (1:1,000) overnight at 4°C. After being washed with 0.5% Tween-20 in Tris-buffered saline, membranes were incubated with HRP-conjugated secondary antibodies (1:5,000). Proteins were visualized using enhanced chemiluminescence reagents (Amersham) and detected with LAS-3000 (Fuji, Tokyo, Japan). Images were quantified with software (TINA, Budapest, Hungary).
RT-PCR.
Expression of fibronectin 1, elastin, collagens (Col1A1 and Col4A1), COX-2, microsomal PGE synthase-2 (mPGES-2), ␤-actin, and GAPDH was estimated by RT-PCR. Total RNAs of lung fibroblasts were isolated by TRIzol reagent (Invitrogen), and cDNA synthesis was performed using 1 g of total RNAs and murine leukemia virus reverse transcriptase (Intron, Sangdaewon, Korea), according to the manufacturer's instructions. Sequences of the PCR primers used were as follows: rat PCR primers: elastin, 5=-TGCCAAATCTGCTGCTAAGG-3= and 5=-TTAGCAGCTTTGGATGCAGC-3=; fibronectin1, 5=-GCCACCTTA-ACTCCTATACC-3= and 5=-GGAATGTTCACAGAAGTGGC-3=; Col1A1, 5=-TGGTGAGAAAGGATCTCCTG-3= and 5=-ATGCC-TCTGTCACCTTGTTC-3=; Col4A1, 5=-GGTGATAAAGGTGAT-GTCGG-3= and 5=-AATTCCAATGCCAGGGAGAC-3=; COX-2, 5=-CGGTGAAACTCTAGACAGAC-3= and 5=-GATACTGGAACT-GCTGGTTG-3=; mPGES-2, 5=-TGACCCTGTACCAGTACAAG-3= and 5=AAACCAGGTAGGTCTTGAGG-3=; GAPDH, 5=-CTCATGAC-CACAGTCCATGC-3= and 5=-TTCAGCTCTGGGATGACCTT-3=; human PCR primers: elastin, 5=-AGGTGTAGGTGGAGCTTTTG-3= and 5=-TCCAATTCCAGGAATTGCCC-3=; fibronectin1, 5=-AT-GATCTGGGACTGTACCTG-3= and 5=-ATGTCCTTGTGTCCT-GATCG-3=; Col1A1, 5=-CAATGGTGCTCCTGGTATTG-3= and 5=-CTTCACCAGGAGATCCTTTG-3=; Col4A1, 5=-GGCGAAATTG-GAGAGAAAGG-3= and 5=-TTCAATCCTACAGAACCCGG-3=; COX-2, 5=-CGGTGAAACTCTAGACAGAC-3= and 5=-GATACTG-GAACTGCTGGTTG-3=; mPGES-2, 5=-CTGAGATCAAGTTCTC-CTCC-3= and 5= TACACATTGGGGGAGATCAG-3=; ␤-actin, 5=-GAAAATCTGGCACCACAC-3= and 5=-GATCTGGGTCATCTT-CTC-3=. PCR products were separated by 1% agarose gel and observed using a Gel-Doc system (Kodak, Rochester, NY). Images were quantified with software (TINA).
Collagen gel contraction assay. The collagen gel contraction assay was performed as described previously (9), with a slight modification. Briefly, lung fibroblasts exposed to CSE in the absence of serum for 24 h were mixed with liquefied collagen solution (BD Biosciences) at a final cell density of 9.0 ϫ 10 5 RFL-6 cells/ml or 5.0 ϫ 10
5
NHLFs/ml and a final collagen concentration of 1.5 mg/ml. Collagen gels were solidified in a 24-well culture plate, gently transferred to a 6-well plate, and incubated with fresh serum-free DMEM or MSC-CM for 24 h in the absence of CSE. Gel images were taken with a digital camera (Nikon D90; Nikon, Tokyo, Japan), and gel area was measured using software (TINA). Staining of intracellular collagen and fibronectin. RFL-6 cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100 in PBS, incubated with 2% BSA in PBS for 1 h at room temperature, incubated with anti-collagen 1 (1:1,000) or anti-fibronectin antibody (1:500) at 4°C overnight, and incubated with FITCconjugated anti-rabbit IgG (1:100) or Alexa Fluor 647-conjugated anti-goat IgG antibody (1: 100) at room temperature for 1 h. Nuclei were stained with 1 g/ml Hoechst 33258 (Calbiochem), and the cells were observed with a confocal laser microscope (LSM 510; Carl Zeiss, Jena, Germany).
Growth factor assay. Growth factors in hMSC-CM were detected using an antibody array chip (Quantibody Human Growth Factor Array 1; RayBiotech, Norcross, GA) according to the manufacturer's instructions, and quantitative data analysis was performed with software (Quantibody Analysis Tool, RayBiotech).
Blocking growth factors in hMSC-CM. To assess proliferative effect of a growth factor in hMSC-CM on proliferation, NHLFs on a 96-well plate (2,500 cells/well) in serum-free DMEM were unexposed or exposed to 4% CSE for 24 h and cultured for an additional 24 h in fresh serum-free DMEM or 10ϫ hMSC that was preincubated with blocking antibody (5 g/ml) for 1 h at 37°C. To determine blockade of hMSC-CM-induced Akt phosphorylation, NHLFs were seeded on a six-well plate and exposed to 4% CSE for 24 h. The next day, NHLFs were washed with PBS and incubated for 30 min with 10ϫ hMSC-CM that was preincubated with blocking antibody as described above.
Exposure of rats to cigarette smoke and administration of MSC-CM. Rats were exposed to cigarette smoke as described in our previous report (18) . In brief, 8-wk-old inbred female Lewis rats (Orient Bio, Seongnam-si, Korea) were exposed to the mainstream smoke of 20 filtered commercial cigarettes, each containing 8.5 mg tar and 0.9 mg nicotine (Eighty Eight Lights) per day for 5 days per week for a period of 6 mo in an inhalation box (50 ϫ 40 ϫ 30 cm). Control animals in cages inhaled clean room air only. Following exposure to cigarette smoke for 6 mo, 20-fold concentrated MSC-CM (0.3 ml) or an equal volume of serum-free DMEM was injected into the tail vein twice per week for the first 5 wk after cessation of cigarette smoke exposure, as Aslam et al. (4) administered MSC-CM in a hyperoxiainduced bronchopulmonary dysplasia model. Rats were killed 2 mo after cessation of cigarette smoke exposure (n ϭ 5-9 per group).
Identification of proliferating lung fibroblasts in rat lungs. Proliferating fibroblasts in rat lungs were detected by double immunostaining with anti-PCNA (1:100) and anti-vimentin (1:50) antibodies and incubated with Alexa Fluor 488-conjugated anti-rabbit IgG (1:100) or Alexa Fluor 555-conjugated anti-mouse IgG antibody (1:100) at room temperature for 1 h. Nuclei were stained with 1 g/ml Hoechst 33258. Total numbers of vimentin (ϩ)/PCNA (ϩ) cells in five randomly chosen fields were counted at ϫ200 magnification. Localization of PCNA and vimentin was confirmed in Z-sections.
Statistical analysis. Data are expressed as the means Ϯ SD. One-way ANOVA and the Mann-Whitney test were used for comparison of data between groups. A P value of Ͻ0.05 was considered statistically significant.
RESULTS

CSE induces apoptotic death in lung fibroblasts.
To determine the effects of CSE on lung fibroblasts, RFL-6 cells and NHLFs were exposed to CSE for 24 h. Results of the MTT assay showed a significant reduction in viability of RFL-6 cells and NHLFs by CSE exposure in a concentration-dependent manner (Fig. 1A) . Similarly, exposure to CSE caused an increase in the subG 1 fraction in FACS analysis (Fig. 1B) and the frequency of TUNEL-positive cells in TUNEL staining (Fig. 1C) . Compared with NHLFs, RFL-6 cells showed a steeper decrease in cell viability, a greater increase in the subG 1 fraction, and a higher frequency of TUNEL-positive cells, indicating that RFL-6 cells are more vulnerable to CSE than NHLFs.
Bone marrow-derived MSC-CM induces proliferation of lung fibroblasts. We next determined the MSC-CM effect on proliferation of lung fibroblast. RFL-6 cells and NHLFs were starved of serum overnight and incubated with fresh serum-free DMEM or several concentrations of MSC-CM for 24 h. In the MTT assay, both rat MSC-CM (rMSC-CM) and human MSC-CM (hMSC-CM) induced an increase in the numbers of live lung fibroblasts in a concentration-dependent manner, whereas the PT did not ( Fig. 2A) . To clarify the proliferative effect of MSC-CM on lung fibroblasts, a BrdU uptake assay was performed (Fig. 2B) . In a similar manner, 5ϫ or 10ϫ MSC-CM of both rat and human origin induced an increase in BrdU uptake in RFL-6 cells and NHLFs, respectively, whereas 1ϫ MSC-CM did not.
MSC-CM inhibits apoptosis and induces proliferation of lung fibroblasts previously damaged by CSE. Next, the effects of rMSC-CM were evaluated in RFL-6 cells that were previously damaged by CSE. After exposure of RFL-6 cells to various concentrations of CSE for 24 h, CSE was removed, culture media was replaced with fresh serum-free DMEM, the PT, or several concentrations of rMSC-CM, and the cells were Rat fetal lung fibroblasts (RFL-6) or normal human lung fibroblasts (NHLFs) were exposed to CSE in the absence of serum for 24 h. Cell viability was determined by 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay (n ϭ 6). B: SubG1 population in fluorescence-activated cell sorting (FACS) analysis. After CSE exposure for 24 h, FACS analysis was performed in RFL-6 cells and NHLFs. FL2-A indicates propidium iodide signal intensity. Each number in the boxes indicates the percentage of the subG1 population in 1 representative experiment, and the graph shows the average percentage of the subG1 population (n ϭ 3). C: DNA nicking after CSE exposure. RFL-6 cells or NHLFs were exposed to CSE for 24 h, and DNA nicks were detected by TUNEL staining. DNA nicks (red) in nuclei (blue) were observed at ϫ100 magnification; arrow heads indicate TUNEL-positive cells. Number of TUNEL(ϩ) cells in 5 randomly chosen fields at ϫ100 magnification (n ϭ 3). Asterisks indicate statistically significant differences (P Ͻ 0.05) between CSE-unexposed and CSE-exposed groups (*RFL-6 cells; **NHLFs).
incubated for an additional 24 h in the absence of CSE. rMSC-CM at all of the tested concentrations from 1ϫ to 10ϫ enhanced the number of live cells in a concentration-dependent manner at each concentration of CSE, whereas the PT did not (Fig. 3A) . Moreover, rMSC-CM greatly attenuated the increase in the subG 1 fraction caused by CSE exposure, compared with serum-free DMEM (Fig. 3B) , and reduced the frequency of TUNEL(ϩ)/annexin V(ϩ) cells (Fig. 3C) . Because we observed the proliferative effect of rMSC-CM at 5ϫ and 10ϫ in Fig. 2B , we evaluated the question of whether 5ϫ and 10ϫ rMSC-CM can improve cell proliferation after previous CSE-induced damage. In RFL-6 cells damaged by 2-8% CSE for 24 h, 5ϫ or 10ϫ rMSC-CM induced a significant increase in BrdU uptake at each concentration of CSE (Fig. 3D) . The above data indicate that rMSC-CM may suppress apoptotic death and enhance cell proliferation in RFL-6 cells after CSE-induced damage. In addition, MSC-CM effect does not seem to be nonspecific, because 10ϫ conditioned media derived from RFL-6 cells, HPASMCs, and NHLFs did not increase number of live lung fibroblasts after previous CSE exposure, similar to serumfree DMEM (data not shown).
MSC-CM reverses CSE-induced biochemical changes related to cell fate. To understand the underlying mechanism of rMSC-CM effects, we observed biochemical changes related to cell fate in RFL-6 cells that were exposed to 4% CSE for 24 h and subsequently cultured in fresh serum-free DMEM or 10ϫ rMSC-CM for an additional 24 h in the absence of CSE. In RFL-6 cells cultured in serum-free DMEM, previous exposure to 4% CSE induced an increase in cleaved caspase-3, p53, p21, and p27, whereas it decreased Akt and p-Akt (Fig. 4) . In contrast, 10ϫ rMSC-CM resulted in successful reversal of CSE-induced biochemical changes, suppressed CSE-induced increases in cleaved caspase-3, p53, p21, and p27, and restored the levels of Akt and p-Akt.
MSC-CM restores CSE-mediated inhibition of collagen gel contraction and ECM protein expression. In addition to cell cycle arrest and apoptosis, impaired repair function, including collagen gel contraction, has been reported in lung fibroblasts of patients with COPD (48) . Therefore, we attempted to determine whether MSC-CM can restore the repair function of lung fibroblasts after previous CSE exposure using collagen gel contraction as an index. Without any stimuli, RFL-6 cells contracted collagen gel by ϳ25%, in terms of gel area (Fig. 5A) . Whereas prior exposure to 4% CSE for 24 h almost completely inhibited collagen gel contraction, 10ϫ rMSC-CM dramatically augmented contraction of collagen gels harboring RFL-6 cells previously exposed to 4% CSE as well as RFL-6 cells not exposed to CSE. In addition to the effect of rMSC-CM on collagen gel contraction, we also assessed the effect of rMSC-CM on expression of COX-2 and mPGES-2 because cigarette smoke induces expression of COX-2 and mPGES-2 in lung fibroblasts in vitro, resulting in increased production of PGE 2 (31) , which suppresses collagen gel contraction (52), and lung fibroblasts from patients with COPD show reduced collagen gel contraction, partly through increased production of PGE 2 (48) . In Fig.  5B , although previous CSE exposure still induced COX-2 mRNA expression in RFL-6 cells in a concentration-dependent manner, 10ϫ rMSC-CM noticeably suppressed CSEinduced COX-2 expression in RFL-6 cells exposed to 8% CSE. Similarly, 10ϫ rMSC-CM also inhibited mPGES-2 expression in RFL-6 cells exposed to 4% and 8% CSE, whereas CSE exposure augmented mPGES-2 expression. Similar to rMSC-CM, hMSC-CM also increased cell viability (Fig. 6A) , restored collagen gel contraction (Fig. 6B) , and suppressed CSE-induced expression of COX-2 and mPGES-2 (Fig. 6C ) in NHLFs previously damaged by 4% CSE for 24 h.
To further investigate restoration of the repair function of lung fibroblasts in addition to collagen gel contraction, we evaluated the question of whether MSC-CM may also restore expression of ECM proteins. Previous CSE exposure to RFL-6 cells resulted in a prominent decrease in mRNAs of elastin, fibronectin 1, ColA1, and Col4A1 in RT-PCR (Fig. 7A) and protein levels of fibronectin and collagen 1 in Western blot in a concentration-dependent manner (Fig. 7B) . In contrast, 10ϫ rMSC-CM, not only induced an increase in basal mRNA levels of fibronectin 1, Col1A1, and Col4A1, and protein levels of fibronectin and collagen 1 in the absence of CSE exposure, but also restored expression of these ECM proteins together with elastin expression in RFL-6 cells damaged by CSE. In accordance, 10ϫ rMSC-CM enhanced immunoreactivity to collagen 1 and fibronectin in the absence of CSE exposure and reversed the decreases in both after CSE exposure (Fig. 7C) . Similar to rMSC-CM, 10ϫ hMSC-CM restored the ECM gene expression that was suppressed in NHLFs previously exposed to 4% CSE (Fig. 7D) . Fig. 3 . Rat MSC-CM rescues lung fibroblasts from CSE-induced damage. After exposure of RFL-6 cells to CSE in the absence of serum for 24 h, the cells were washed and incubated with fresh serum-free DMEM, the PT, or concentrated rMSC-CM for 24 h in the absence of CSE. A: cell survival was estimated by MTT assay (n ϭ 4). B: SubG1 population in FACS analysis (n ϭ 3). C: TUNEL (red) and annexin V (green) staining with nuclear staining (blue) (n ϭ 3). D: cell proliferation was assessed by BrdU uptake assay (n ϭ 4). In A and D, * indicates a statistically significant difference (P Ͻ 0.05) compared with cells grown in serum-free DMEM at each concentration of CSE. In B and C, * indicates a statistically significant difference (P Ͻ 0.05) between 2 compared groups.
The PI3K/Akt pathway, in part, mediates MSC-CM effects on proliferation, collagen gel contraction, and ECM protein expression. As shown in Fig. 4 , Akt and p-Akt were decreased after CSE exposure, and MSC-CM resulted in restoration of the levels of both. Because the PI3K/Akt pathway is known to act as a survival signaling hub (30) and to be involved in ECM protein expression (25, 26) , we investigated the contribution of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway to the effects of MSC-CM. LY294002, a PI3K inhibitor, inhibited Akt phosphorylation induced by MSC-CM (Fig. 8A) . In the absence of MSC-CM, LY294002 caused a small but significant decrease in the viability of RFL-6 cells previously damaged by 2% or 4% CSE [DMEM/LY(-) vs. DMEM/LY(ϩ), Fig. 7B ]. Similarly, but to a greater extent, LY294002 significantly attenuated the MSC-CM-mediated increase in viability of RFL-6 cells damaged by 2% or 4% CSE [10ϫ rMSC-CM/LY(-) vs. 10ϫ rMSC-CM/LY(ϩ)]. Fig. 4 . Rat MSC-CM reverses CSE-induced biochemical changes related to cell fate. Following exposure to CSE in the absence of serum for 24 h, RFL-6 cells were washed and treated with serum-free DMEM or 10ϫ rMSC-CM for an additional 24 h in the absence of CSE. Western blot was performed for detection of cleaved caspase-3, p53, p21, p27, Akt, p-Akt, and GAPDH. Asterisks indicate a statistically significant difference (P Ͻ 0.05, n ϭ 3).
In Fig. 8C , LY294002 induced a decrease in basal expression of mRNAs of elastin, fibronectin 1, Col1A1, and Col4A1 in the absence of 10ϫ rMSC-CM and CSE exposure (first vs. second lanes). After CSE exposure for 24 h and incubation in fresh DMEM for an additional 24 h, ECM protein expression was almost completely inhibited by LY294002 (third vs. fourth lanes). A similar pattern of inhibition by LY294002 was observed in RFL-6 cells treated with 10ϫ rMSC-CM. Whereas LY294002 induced slight suppression of the MSC-CM-induced increase in expression of elastin, fibronectin 1, and Col1A1 in the absence of CSE exposure (fifth vs. sixth lanes), it suppressed MSC-CM-mediated increase in ECM protein expression to a much greater extent after CSE exposure (seventh vs. eighth lanes). In accordance with cell viability and ECM protein expression, LY294002 also significantly inhibited MSC-CM-induced augmentation of gel contraction after previous CSE exposure while causing nonsignificant reduction of rMSC-CM-induced augmentation of collagen gel contraction in the absence of CSE exposure (Fig. 8D) . Similarly, LY294002 also inhibited the hMSC-CM effects on ECM gene expression (Fig. 9A ) and collagen gel contraction (Fig. 9B ) in CSE-damaged NHLFs.
Identification of growth factors in hMSC-CM. To identify growth factors in 10ϫ hMSC-CM, we measured concentrations of 40 growth factors by using an antibody array chip (Table 1) . Among them, we assessed involvement of FGF2, TGF-␤ 1 , and VEGF, which are known to enhance fibroblast proliferation (27, 28, 47) , with each blocking antibody. Antibodies against FGF2, TGF-␤ 1 , and VEGF significantly suppressed hMSC-CM-induced proliferation of NHLFs that were not exposed to CSE (Fig. 10A) . However, the inhibitory effect of anti-TGF-␤ 1 antibody was noticeably diminished in NHLFs previously exposed to 4% CSE, whereas anti-FGF2 antibody still strongly inhibited increase in the number of live cells in CSE-exposed NHLFs to a similar degree as in CSE-unexposed NHLFs. In accordance, anti-FGF2 antibody remarkably blocked hMSC-CM-induced Akt phosphorylation in previously CSE-exposed NHLFs, whereas anti-TGF-␤ 1 marginally Fig. 5 . Rat MSC-CM restores collagen gel contraction suppressed by CSE exposure. A: following exposure to 0 or 4% CSE in the absence of serum for 24 h, RFL-6 cells were detached and embedded into collagen gel lattices at a density of 9 ϫ 10 5 cells/ml gel, and the gels were incubated in a 6-well plate with serum-free DMEM or 10ϫ rMSC-CM for 24 h in the absence of CSE. After gel images were taken, the percentage of gel area relative to the area of gel containing no cells was calculated (n ϭ 4). B: suppression of CSE-induced expression of cyclooxygenase (COX)-2 and microsomal PGE synthase-2 (mPGES-2) by rMSC-CM. Following exposure to CSE in the absence of serum for 24 h, RFL-6 cells were washed and treated with serum-free DMEM or 10ϫ rMSC-CM for 24 h in the absence of CSE. RT-PCR was performed for determination of mRNA expression of COX-2 and mPGES-2 (n ϭ 3). Asterisks indicate statistically significant differences (P Ͻ 0.05).
inhibited Akt phosphorylation (Fig. 10B) . Anti-VEGF antibody marginally but significantly reduced the number of live NHLFs both in the absence and presence of previous CSE exposure (Fig. 10A) ; however, it had no effect on MSC-CMinduced Akt phosphorylation (Fig. 10B) .
MSC-CM induces proliferation of lung fibroblasts in rats exposed to cigarette smoke. In the above experiments, we observed that rMSC-CM enhanced proliferation of RFL-6 cells damaged by CSE exposure in vitro. Therefore, we evaluated the in vivo effect of MSC-CM on proliferation of lung fibroblasts in a rat model. Female Lewis rats were exposed to cigarette smoke for 6 mo, treated with rMSC-CM for the first 5 wk after cessation of cigarette smoke exposure, and killed 2 mo after cessation of cigarette smoke exposure. Consistent with the in vitro effect of rMSC-CM on proliferation of lung fibroblasts, the numbers of proliferating lung fibroblasts [vimentin(ϩ)/PCNA(ϩ) cells] in pulmonary alveoli showed a significant increase in the cigarette smoke-exposed and rMSC-CM-treated (SMϩrMSC-CM) group, compared with the cigarette smoke-exposed (SM) group, whereas exposure to cigarette smoke resulted in significantly suppressed proliferation of lung fibroblasts in the SM group, compared with the room air-exposed (CON) group, even with cessation of exposure to cigarette smoke for a period of 2 mo (Fig. 11, A and B) . In addition, similar to the in vitro data, the level of p-Akt showed a significant increase in the rMSC-CM and SMϩrMSC-CM Fig. 6 . Human MSC-CM enhances survival and restores collagen gel contraction in NHLFs previously exposed to CSE. A: MTT assay. After exposure of NHLFs to 0 -8% CSE in the absence of serum for 24 h, the cells were washed and incubated with fresh serumfree DMEM or 10ϫ hMSC-CM for 24 h in the absence of CSE (n ϭ 6). B: following exposure to 0 or 4% CSE in the absence of serum for 24 h, NHLFs were detached and embedded into collagen gel lattices at a density of 5 ϫ 10 5 cells/ml gel, and the gels were incubated in a 6-well plate with serum-free DMEM or 10ϫ hMSC-CM for 24 h in the absence of CSE (n ϭ 4). C: suppression of CSE-induced expression of COX-2 and mPGES-2 by hMSC-CM. Following exposure to CSE in the absence of serum for 24 h, NHLFs were washed and treated with serum-free DMEM or 10ϫ hMSC-CM for 24 h in the absence of CSE (n ϭ 3). Asterisks indicate statistically significant differences between 2 compared groups (P Ͻ 0.05).
groups, compared with the CON and SM groups, respectively (Fig. 11C) .
DISCUSSION
In our previous study, we demonstrated that bone marrow cells and MSCs restored emphysematous change caused by chronic exposure of rats to cigarette smoke (18) . Of note, we did not detect donor bone marrow cells and MSCs at 2 mo after administration in recipients= lungs; however, emphysematous change was almost completely restored at 2 mo after cell administration. Therefore, we suggested that repair of emphysematous lung is mediated through a paracrine action, which was supported by recovery of emphysematous lungs by MSC-CM. The effects of MSC-CM do not appear to be nonspecific because the conditioned media from other types of cells including lung fibroblasts and PASMCs did not rescue the target cells from CSE-induced cytotoxicity (18) . To support the beneficial effects of MSC-CM in vivo, we demonstrated in this study that MSC-CM attenuated cytotoxicity, suppression of proliferation, and functional impairment in lung fibroblasts in vitro after exposure to CSE.
Cigarette smoking is known to cause cytotoxicity and functional impairment in lung fibroblasts. CSE was found to cause apoptosis in lung fibroblasts through oxidative stress, which was reduced by antioxidants, including N-acetyl cysteine (10) . In addition, on the basis of the findings that long-term exposure of lung fibroblasts to CSE resulted in an increase in the number of ␤-galactosidase-positive cells and caused changes in expression of ataxia telangiectasia mutated, p53, p21, phosphorylated-retinoblastoma (p-RB), and p16 in favor of cell cycle arrest, Nyunoya et al. (38) reported that CSE led to cellular senescence. Although we demonstrated a similar change in p21, we only observed an increase in the subG 1 fraction instead of G 0 /G 1 arrest in FACS analysis and increased frequencies of TUNEL(ϩ)/annexin V(ϩ) cells. This discrepancy may originate from different responses to CSE in different cell strains. Similar to our data showing a higher susceptibility of RFL-6 cells to CSE than NHLFs, CSE-exposure has been observed to produce differential induction of apoptosis in several strains of human lung fibroblasts (6) . p21, a cyclin-dependent kinase (CDK) inhibitor, leads to cell cycle arrest and apoptosis (1) and is also proposed to play an important pathological role in senescence and inflammation caused by cigarette smoking (38, 49, 50) . In addition to the increase in p21, Nyunoya et al. (38) observed an increase in p53 after CSE exposure (38) . Although they suggested involvement of the p53-p21-p-RB pathway in senescence, p53 has also been shown to elicit apoptosis (16) . Similarly, p27, another CDK inhibitor, was found to cause, not only cell cycle arrest, but also apoptosis (11) .
In contrast to the increases in p21 and p27, CSE exposure resulted in decreased levels of Akt and p-Akt, and MSC-CM induced a reversal of the decrease. Akt is a key signaling factor that is well known to promote survival or cell proliferation. Akt enhances cell survival through inhibition of proapoptotic proteins, including Bcl-2-associated death promoter and forkhead box, and activation of antiapoptotic proteins, including murine double min 2, resulting in p53 degradation (30) . It also promotes cell proliferation by inhibiting interaction of p21 with PCNA and promoting assembly of cyclin D1:cyclin-dependent kinase 4 complex. Of note, a pathological significance of Akt in maintenance of alveolar architecture is evidenced by the findings that inhibition of the PI3K/Akt pathway by wortmannin aggravated hyperoxia-induced bronchopulmonary dysplasia, and forced expression of constitutively active Akt attenuated hyperoxia-induced airspace enlargement with suppression of apoptosis (2) . However, although the authors showed that adenoviral expression of Akt attenuated hyperoxia-induced lung injury and rescued type 2 alveolar epithelial cells from hyperoxia-induced apoptosis, it remains unknown whether Akt may play a critical role in survival, proliferation, and function in other cell types including lung fibroblasts for successful alveolarization.
In addition to its actions on cell survival and proliferation, the PI3K/Akt pathway is also involved in ECM production. In human lung fibroblasts, Col1A1 mRNA is stabilized in a PI3K-dependent manner (40) , and bleomycin-induced collagen production is regulated by PI3K/Akt (27) . LY294002 was found to completely abolish collagen production and to induce a significant decrease in secretion of laminin ␤2 and fibronectin from keloid fibroblasts (26) . In human embryonic lung fibroblasts, TGF-␤ induced elastin expression, which was blocked by LY294002 or Akt2 siRNA (25) . Similarly, fibronectin assembly was impaired in Akt1-null mouse embryonic fibroblasts (46) .
Recently, the PI3K/Akt pathway was reported to regulate proliferation and collagen production in lung fibroblasts exposed to bleomycin (27) . On the basis of the findings that bleomycin induced VEGF release from lung fibroblasts, and that VEGF caused proliferation and collagen production, this report suggested that VEGF was in part responsible for fibroblast activation. However, a neutralizing antibody to VEGF did not completely inhibit the phenomena, whereas LY294002 induced complete blockaded of bleomycin-induced proliferation and collagen production. Therefore, the authors suggested the possible involvement of additional factors in collagen production and proliferation of lung fibroblasts via PI3K/Akt, mentioning several possible candidate factors, including platelet-derived growth factor, TGF-␤, and FGF2. Of particular interest, MSCs have been reported to secrete some candidate factors believed to enhance cell survival and proliferation. Kinnaird et al. (22) reported on rescue of muscles by MSCs in a hind limb ischemia model, possibly via paracrine mechanisms. They observed release of several growth factors by MSCs, including VEGF and FGF2, and MSC-CM was found to enhance proliferation of endothelial cells and vascular smooth muscle cells, an effect that was partially blocked by Fig. 7 . MSC-CM restores expression of extracellular matrix (ECM) proteins that are suppressed by CSE exposure. Following exposure to CSE in the absence of serum for 24 h, RFL-6 cells or NHLFs were washed and incubated with fresh serum-free DMEM or 10ϫ MSC-CM (rMSC-CM or hMSC-CM, respectively) for an additional 24 h in the absence of CSE. A: expression of mRNAs of elastin, fibronectin, Col1A1, Col4A1, and GAPDH in RT-PCR in RFL-6 cells (n ϭ 3). B: protein levels of fibronectin, collagen 1, and ␤-actin in Western blot (n ϭ 3). C: collagen 1 (green) and fibronectin (red) in RFL-6 cells visualized by immunostaining together with nuclear staining (blue) at ϫ630 magnification. D: expression of mRNAs of elastin, fibronectin, Col1A1, Col4A1, and GAPDH in RT-PCR in NHLFs (n ϭ 3). Asterisks denote a statistically significant difference (P Ͻ 0.05) between 2 compared groups. Fig. 8 . The phosphatidylinositol 3-kinase (PI3K)/Akt pathway mediates rMSC-CM effects. A: inhibition of rMSC-CM-induced Akt phosphorylation by LY294002. RFL-6 cells were starved of serum overnight and treated with 20 M LY294002, 30 min before addition of 10ϫ rMSC-CM. Cells were harvested 30 min after addition of 10ϫ rMSC-CM, and Akt phosphorylation was determined by Western blot. Asterisks denote a statistically significant difference (P Ͻ 0.05, n ϭ 3). B: LY294002 inhibits rMSC-CM-induced increase in cell survival. C: LY294002 suppresses rMSC-CM-induced restoration of ECM protein expression. In B and C, RFL-6 cells were exposed to CSE in the absence of serum for 24 h and incubated with fresh serum-free DMEM or 10ϫ rMSC-CM for 24 h in the absence of CSE. LY294002 (20 M) was added to RFL-6 cells 30 min before replacement of media with fresh serum-free DMEM or 10ϫ rMSC-CM containing 20 M LY294002. After 24 h, cell viability was measured by MTT assay (B), and expression of ECM proteins was determined by RT-PCR (C). In B, asterisks indicate a statistically significant difference (P Ͻ 0.05, n ϭ 4) at each concentration of CSE [*DMEM/LY(-) vs. DMEM/LY(ϩ); **10ϫ rMSC-CM/LY(-) vs. 10ϫ rMSC-CM/LY(ϩ)]. In C, asterisks denote a statistically significant difference between 2 compared groups (P Ͻ 0.05, n ϭ 4). D: LY294002 inhibits rMSC-CM-induced restoration of collagen gel contraction. RFL-6 cells exposed to 4% CSE in the absence of serum for 24 h were embedded in collagen gel lattices. The gels were incubated with serum-free DMEM or 10ϫ rMSC-CM without CSE in the absence or presence of 20 M LY294002 for 24 h. Asterisks indicate statistically significant differences (P Ͻ 0.05, n ϭ 4).
anti-VEGF and anti-FGF antibodies. Both VEGF (27) and FGF (28) have been shown to induce proliferation of lung fibroblasts. In addition, TGF-␤ 1 is also produced by MSCs (12) and enhances proliferation of fibroblasts (47) , collagen production, and collagen gel contraction (33) . Mice deficient in Smad3, which mediates the TGF-␤ signal, develop air space enlargement with age (7), and CSE was found to induce abnormal reduction of Smad3 expression in lung fibroblasts from patients with COPD (51) . These data suggest that TGF-␤-Smad signaling may play an important role in maintenance or repair of lung architecture. Salazar et al. (42) recently reported that MSCs produced Wnt and TGF-␤ 1 , molecules responsible for proliferation of lung fibroblasts and collagen expression, respectively.
In the growth factor assay, we identified some soluble factors potentially responsible for lung repair and assessed contribution of FGF2, VEGF, and TGF-␤ 1 to NHLFs. Interestingly, whereas all the tested blocking antibodies significantly blocked NHLFs that were not previously exposed to CSE, only anti-FGF2 antibody efficiently suppressed proliferation in NHLFs previously exposed to CSE to a similar degree as in NHLFs unexposed to CSE. These data imply that FGF2 may play a major role in repair of damaged lung fibroblasts, compared with VEGF and TGF-␤. This discrepancy may originate from differential suppression of related signaling pathways after CSE exposure. Otherwise, MSC-CM may selectively induce or restore some signaling pathways including FGF2/Akt pathway. To solve this question, alteration in various signaling pathways involved in CSE-induced damage and MSC-CM-mediated recovery needs to be assessed and compared in future study.
FGF2 is known to induce lung fibroblast proliferation (28, 44) and Akt phosphorylation in fibroblasts (20) . Furthermore, FGF2 causes lung repair in an elastase-induced emphysema Fig. 9 . The PI3K/Akt pathway mediates human MSC-CM effects. A: LY294002 suppresses human MSC-CM-induced restoration of ECM protein expression. NHLFs were exposed to CSE in the absence of serum for 24 h and incubated with fresh serum-free DMEM or 10ϫ hMSC-CM for 24 h in the absence of CSE. LY294002 (20 M) was added to NHLFs 30 min before replacement of media with fresh serum-free DMEM or 10ϫ hMSC-CM containing 20 M LY294002. After 24 h, expression of ECM proteins was determined by RT-PCR (n ϭ 4). B: LY294002 inhibits hMSC-CM-induced restoration of collagen gel contraction. NHLFs exposed to 4% CSE in the absence of serum for 24 h were embedded in collagen gel lattices. The gels were incubated with serum-free DMEM or hMSC-CM without CSE in the presence or absence of 20 M LY294002 for 24 h (n ϭ 4). Asterisks indicate a statistically significant differences (P Ͻ 0.05). NS, not statistically significant. model along with recovery of pulmonary blood flow (35) . In our previous study (18) , we observed that MSC-CM administration alleviated emphysematous change, caused angiogenesis, and reduced right ventricular systolic pressure that was elevated by exposure to cigarette smoke for 6 mo. As FGF2 is also a potent angiogenic factor as well as a fibroblast mitogen, it may work in lung repair by induction of angiogenesis and reconstruction of alveolar architecture, resulting in alveolar repair. Against this beneficial effect on emphysema, however, FGF2 may be harmful through involvement in airway remodeling. FGF2 causes bronchial smooth muscle cell proliferation synergistically with TGF-␤ 1 (8) and bronchial expression, and FGF2 and FGF receptor 1 are enhanced in patients with COPD (24) . Another potential adverse effect of FGF2 is pulmonary fibrosis (19) .
In hMSC-CM, we found the coexistence of both fibrogenic and antifibrogenic factors (Table 1 ). In addition to FGF2, TGF-␤ 1 is a well-known factor responsible for pulmonary fibrosis (3), and VEGF aggravated TGF-␤ 1 -induced fibrogenic process even with concomitant amelioration of pulmonary hypertension (14) . Opposite to the profibrogenic factors, keratinocyte growth factor was demonstrated to ameliorate bleomycin-induced pulmonary fibrosis (41) , and hepatocyte growth factor caused improvement of pulmonary fibrosis and apoptosis of myofibroblast in bleomycin-treated mice (32) . In addition, PGE 2 secreted from MSCs (37) may play an important regulatory role in lung repair, possibly through suppressing exaggerated fibroblast proliferation by inducing fibroblast apoptosis (29) . By the coexistence of various profibrogenic and antifibrogenic factors in MSC-CM, it is difficult to expect their relative contribution to MSC-CM-mediated proliferation and functional recovery of lung fibroblast in lung repair. In addition, this question becomes more complicated by the possibility that related signaling pathways may be altered by CSE exposure and MSC-CM treatment, which was evidenced by differential blockade of lung fibroblast proliferation by the blocking antibodies in between the absence and presence of previous CSE exposure.
In this study, LY294002 blocked the effects of MSC-CM on cell proliferation, expression of ECM proteins, and collagen gel contraction to a greater degree in lung fibroblasts previously exposed to CSE than in CSE-unexposed lung fibroblasts. The enhanced inhibitory effect of LY294002 may be caused by the restoration of Akt/p-Akt levels by MSC-CM in lung fibroblasts previously damaged by CSE, implying that Akt may play an important role in repair of CSE-damaged lung fibroblast. Recently, we reported that active Akt was preferentially degraded by cigarette smoke through the ubiquitin proteasome system (21) . In this previous report, forced expression of active (myristoylated) Akt rescued CSE-exposed lung fibroblasts, whereas overexpression of inactive Akt (T308A and S473A double mutant) did not. Also, we observed reduction of Akt and p-Akt together with enhanced Akt ubiquitination in rat lungs 3 mo after exposure to cigarette smoke. However, in this study, we did not notice significant reduction of Akt and p-Akt in the SM group compared with the CON group, whereas rMSC-CM administration induces Akt phosphorylation in the SMϩrMSC-CM group. This discrepancy may originate from a lapse of time after cessation of cigarette smoking. In this study, we determined changes in Akt and p-Akt 2 mo after cessation of cigarette smoking, whereas Akt/p-Akt reduction was observed after 3-mo smoking without a lapse of time in the previous study (21) . Therefore, recovery of Akt may occur during the period of 2 mo between lung collection and cessation of cigarette smoking. However, the restoration of Akt just to the "normal" level after cessation of cigarette smoking does not appear sufficient for repair of damaged lung because the significant emphysematous change was still observed in the SM rat lungs in our previous study (18) . Consistent with this idea, forced expression of active Akt in vivo resumed alveolar development in a bronchopulmonary dysplasia model caused by hyperoxia, which resulted in p-Akt reduction (2) .
Considering regional fibroblast heterogeneity in the lung (23), the effects of MSC-CM on peribronchial and alveolar fibroblasts need to be critically investigated for future clinical application of MSC-CM in treatment of COPD. Use of MSC-CM may result in exaggerated peribronchial fibrosis and myofibroblast differentiation that are already caused by cigarette smoking or cause alveolar interstitial fibrosis, resulting in exacerbation of airflow limitation or impairment of gas exchange, respectively. On the other hand, MSC-CM may play a beneficial role in epithelial regeneration by production of ECM from alveolar fibroblasts, providing an appropriate basis for epithelial regeneration. We did not observe an increase in ␣-smooth muscle actin in rMSC-CM-treated RFL-6 cells, which is indicative of myofibroblast differentiation (data not shown). In addition, we did not notice either exaggerated collagen deposit surrounding airways (data not shown) or thickening of alveolar walls in the SMϩrMSC-CM group (18) , whereas proliferating alveolar fibroblasts increased in alveolar walls. Therefore, the possibility of exacerbation of peribronchial and interstitial fibrosis appears to be low, whereas MSC-CM would be beneficial in alveolar regeneration. However, as we determined the potential hazardous effects of MSC-CM on peribronchial and interstitial fibrosis only on a morphological basis, functional in vivo analyses, including assessment of airflow and gas exchange, and response to MSC-CM in different lung fibroblast populations, especially in peribronchial and alveolar fibroblasts, must be carefully fulfilled to attain a better understanding of the reparative roles and future clinical application of MSC-CM for treatment of COPD.
Finally, as functional impairments including reductions in cell proliferation (17) , chemotaxis, and collagen gel contraction (48) are found in lung fibroblasts from patients with COPD, the response to MSC-CM remains to be determined in Fig. 10 . Involvement of fibroblast growth factor 2 (FGF2), transforming growth factor (TGF)-␤1, and vascular endothelial growth factor (VEGF) in hMSC-CM-induced proliferation, increase in survival, and Akt phosphorylation in NHLFs. A: MTT assay. NHLFs in serum-free DMEM were unexposed or exposed to 4% CSE for 24 h and cultured for an additional 24 h in fresh serum-free DMEM or 10ϫ hMSC-CM that was preincubated with blocking antibody (5 g/ml) for 1 h at 37°C. Number of live cells was assessed by MTT assay (n ϭ 6). B: Akt phosphorylation. NHLFs were exposed to 4% CSE for 24 h, washed with PBS, and cultured for 30 min with 10ϫ hMSC-CM that was preincubated with blocking antibodies (n ϭ 3). Asterisks indicate a statistically significant difference (P Ͻ 0.05).
these potentially dysfunctional fibroblasts to confirm the beneficial effects of MSC-CM. . Rat MSC-CM administration induces proliferation of alveolar fibroblasts in rat lungs exposed to cigarette smoke. Rats were exposed to cigarette smoke for 6 mo, subject to rMSC-CM administration for the first 5 wk after cessation of cigarette smoke exposure, and killed 2 mo after cessation of cigarette smoke exposure. A: confocal images of proliferating alveolar fibroblasts. Proliferating fibroblasts were detected by double immunostaining with anti-vimentin and anti-proliferating cell nuclear antigen (PCNA) antibodies, and double-positive cells were confirmed by Z-sections. B: numbers of vimentin(ϩ)/ PCNA(ϩ) cells. Numbers of vimentin(ϩ)/PCNA(ϩ) cells were counted at ϫ200 magnification in 5 randomly chosen fields. C: p-Akt levels in rat lung homogenates. CON, SM, rMSC-CM, and SMϩrMSC-CM denote the room airexposed, cigarette smoke-exposed, room air-exposed and rMSC-CM-treated, and cigarette smoke-exposed and rMSC-CM-treated groups, respectively. Asterisks indicate a statistically significant difference between 2 compared groups (P Ͻ 0.05). Number of samples; CON ϭ 6, SM ϭ 5, rMSC-CM ϭ 9, and SMϩrMSC-CM ϭ 9. 
